Teleneurology defines the use of mobile technology to deliver neurological care remotely, including care for stroke, movement disorders like Parkinson’s disease, Epilepsy, Dementia, and other neurological conditions. Teleneurology can improve health care access for thousands around the globe, from those living in urban locations to those in remote, rural locations. Evidence shows that individuals with Parkinson’s disease prefer personal connection with a remote specialist to their local clinician. A randomized controlled trial of “virtual house calls” or video visits with individuals diagnosed with Parkinson’s disease demonstrates patient preference for the remote specialist vs their local clinician after one year.
Teleneurology can also be more affordable and can reduce in-person visits of patients with mobility issues. A recent systematic review describes both the limitations and potential benefits of teleneurology to improve care for patients with chronic neurological conditions.
Mobile technologies, especially smartphones and wearable sensors, can provide objective, frequent assessments of neurological conditions, and neurological care will expand and migrate from hospitals and clinics to homes and mobile devices, incorporate systems of asynchronous communications and integrate clinicians with diverse skill sets.
References – further reading
Dorsey ER, Glidden AM, Holloway MR, Birbeck GL, Schwamm LH (May 2018). “Teleneurology and mobile technologies: the future of neurological care”. Nature Reviews. Neurology. 14 (5): 285–297. doi:10.1038/nrneurol.2018.31. PMID 29623949. S2CID 4620042.
Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, et al. (September 2017). “National randomized controlled trial of virtual house calls for Parkinson disease”. Neurology. 89 (11): 1152–1161. doi:10.1212/WNL.0000000000004357. PMC 5595275. PMID 28814455.
Ben-Pazi H, Browne P, Chan P, Cubo E, Guttman M, Hassan A, et al. (April 2018). “The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach”. Current Neurology and Neuroscience Reports. 18 (5): 26. doi:10.1007/s11910-018-0834-6. PMID 29654523. S2CID 4850577.
Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, et al. (September 2017). “National randomized controlled trial of virtual house calls for Parkinson disease”. Neurology. 89 (11): 1152–1161. doi:10.1212/WNL.0000000000004357. PMID 28814455.